Low-grade inflammation and arterial wave reflection in patients with chronic fatigue syndrome

Clinical Science

Volumn 114, Issue 7-8, 2008, Pages 561-566

  Spence, Vance A ^a   Kennedy, Gwen ^a   Belch, Jill J F ^a   Hill, Alexander ^a   Khan, Faisel ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Arterial stiffness; Augmentation index; Cardiovascular risk; Chronic fatigue syndrome; Inflammation; Pulse wave analysis

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1; ISOPROSTANE; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; BIOLOGICAL MARKER; DRUG DERIVATIVE; PROSTAGLANDIN F2 ALPHA; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTERIAL STIFFNESS; ARTERIAL WAVE REFLECTION; ARTERY BLOOD FLOW; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHRONIC FATIGUE SYNDROME; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; MALE; MULTIPLE REGRESSION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; UNCERTAINTY; WAVEFORM; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RADIAL ARTERY; RISK FACTOR; VASCULAR RESISTANCE;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DINOPROST; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; RADIAL ARTERY; RISK FACTORS; VASCULAR RESISTANCE;

EID: 41949091051     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20070274     Document Type: Article

References (54)

1. Nijs, J., Meeus, M., McGregor, N. R. et al. (2005) Chronic fatigue syndrome: exercise performance related to immune dysfunction. Med. Sci. Sports Exercise 37, 1647-1654
2. Yoshiuchi, K., Quigley, K. S., Ohashi, K., Yamamoto, Y. and Natelson, B. H. (2004) Use of time-frequency analysis to investigate temporal patterns of cardiac autonomic response during head-up tilt in chronic fatigue syndrome. Auton. Neurosci. Basic Sci. 113, 55-62
3. DeBecker, P., Roeykens, J., Reynders, M., McGregor, N. and De Meirleir, K. (2000) Exercise capacity in chronic fatigue syndrome. Arch. Intern. Med. 160, 3270-3277
4. Stewart, J. M. (2000) Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion. Pediatr. Res. 48, 218-226
5. Spence, V. A. and Stewart, J. M. (2004) Standing up for ME: cardiovascular mechanisms of orthostatic intolerance. Biologist 51, 65-70
6. Peckerman, A., Lamanca, J. J., Dahl, K. A., Chemitiganti, R., Qureishi, B. and Natelson, B. H. (2003) Abnormal impedance cardiography predicts symptom severity in chronic fatigue syndrome. Am. J. Med. Sci. 326, 55-60
7. Richards, R. S., Roberts, T. K., McGregor, N. R., Dunstan, R. H. and Butt, H. L. (2000) Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome. Redox Rep. 5, 35-41
8. Manuel-Y-Keenoy, B., Moorkens, G., Vertommen, J. and De Leeuw, I. (2001) Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome. Life Sci. 68, 2037-2049
9. Vecchiet, J., Cipollone, F., Falasca, K. et al. (2003) Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci. Lett. 335, 151-154
10. Kennedy, G., Spence, V. A., McLaren, M., Hill, A., Underwood, C. and Belch, J. J. F. (2005) Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radical Biol. Med. 39, 584-589
11. Kennedy, G., Spence, V. A., Underwood, C. and Belch, J. J. F. (2004) Increased neutrophil apoptosis in chronic fatigue syndrome. J. Clin. Pathol. 57, 891-893
12. Rifai, N. and Ridker, P. M. (2001) High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin. Chem. 47, 403-411
13. Bassuk, S. S., Rifai, N. and and Ridker, P. M. (2004) High-sensitivity C-reactive protein: clinical importance. Curr. Prob. Cardiol. 29, 439-493
14. Buchwald, D., Wener, M. H., Pearlman, T. and Kith, P. (1997) Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. J. Rheumatol. 24, 372-376
15. Booth, A. D., Wallace, S., McEniery, C. M. et al. (2004) Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum. 50, 581-588
16. Yasmin, McEniery, C. M., Wallace, S., Mackenzie, I. S., Cockcroft, J. R. and Wilkinson, I. B. (2004) C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler. Thromb. Vasc. Biol. 24, 969-974
17. Kullo, I. J., Seward, J. B., Bailey, K. R. et al. (2005) C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am. J. Hypertens. 18, 1123-1129
18. Vlachopoulos, C., Dima, I., Aznaouridis, K. et al. (2005) Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 112, 2193-2200
19. Van de Putte, E. M., Uiterwaal, C. S. P. M., Bots, M. L., Kuis, W., Kimpen, J. L. L. and Engelbert, R. H. H. (2005) Is chronic fatigue syndrome a connective tissue disorder? A cross-sectional study in adolescents. Pediatrics 115, 415-422
20. Mattace-Raso, F. U. S., Van der Cammen, T. J. M., Hofman, A. et al. (2006) Arterial stiffness and risk of coronary heart disease and stroke. The Rotterdam study. Circulation 113, 657-663
21. Nürnberger, J., Keflioglu-Scheiber, A., Saez, A. M. O., Wenzel, R. R., Philipp, T. and Schäfers, R. F. (2002) Augmentation index is associated with cardiovascular risk. J. Hypertens. 20, 2407-2414
22. Coviv, A., Haydar, A. A., Bhamra Ariza, P., Taomir-Gusbeth, P. and Goldsmith, D. J. (2005) Aortic pulse wave velocity and arterial wave reflection predict the extent and severity of coronary artery disease in chronic kidney disease patients. J. Nephrol. 18, 388-396
23. Weber, T., Auer, J., O'Rourke, M. F. et al. (2005) Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions. Eur. Heart J. 26, 2657-2663
24. Chirinos, J. A., Zambrano, J. P., Chakko, S. et al. (2005) Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension 45, 980-985
25. Laurent, S., Cockcroft, J., Van Bortel, L. et al. (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur. Heart J. 27, 2588-2605
26. Agabiti-Rosei, E., Mancia, G., O'Rourke, M. F. et al. (2007) Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension 50, 154-160
27. London, G. M., Blacher, J., Pannier, B., Guerin, A. P., Marchais, S. J. and Safar, M. E. (2001) Arterial wave reflections and survival in end-stage renal failure. Hypertension 38, 434-438
28. Fukuda, K., Straus, S., Hickie, I. et al. (1994) Chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann. Intern. Med. 121, 953-959
29. 2 isoprosotanes as an index of oxidative stress in vivo. Free Radical Biol. Med. 28, 505-513
30. Chen, C. H., Nevo, E., Fetics, B. et al. (1997) Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation 95, 1827-1836
31. Weber, T., Auer, J., O'Rourke, M. F. et al. (2004) Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 109, 184-189
32. Wilkinson, I. B., MacCallum, H., Flint, L., Cockcroft, J. R., Newby, D. E. and Webb, D. J. (2000) The influence of heart rate on augmentation index and central arterial pressure in humans. J. Physiol. 525, 263-270
33. Lerner, A. M., Goldstein, J., Change, C. H. et al. (1997) Cardiac involvement in patients with chronic fatigue syndrome as documented with Holter and biopsy data in Birmingham. Michigan. 1991-1993. Infect. Dis. Clin. Pract. 6, 327-333
34. Lerner, A. M., Dworkin, H. J., Sayved, T. et al. (2004) Prevalence of abnormal cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-Barr virus and/or cytomegalovirus in patients with chronic fatigue syndrome. In Vivo 18, 417-424
35. Jason, L. A., Corradi, K., Gress, S., Williams, S. and Torres-Harding, S. (2006) Causes of death among patients with chronic fatigue syndrome. Health Care Women Int. 27, 615-626
36. Ridker, P. M. (2007) C-reactive protein and the prediction of cardiovascular evens among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J. Am. Coll. Cardiol. 49, 2129-2138
37. Hickie, I., Davenport, T., Wakefield, D. et al. (2006) Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. Br. Med. J. 333, 575
38. Jason, L. A., Corradi, K., Torres-Harding, S., Taylor, R. R. and King, C. (2005) Chronic fatigue syndrome: the need for subtypes. Neuropsychol. Rev. 15, 29-58
39. Cheung, Y. F., Ho, M. H. K., Tam, S. C. F. and Yung, T. C. (2004) Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease. Heart 90, 1281-1285
40. Turesson, C., Jacobsson, L., Ryden Ahlgren, A., Sturfelt, G., Wollmer, P. and Lanne, T. (2005) Increased stiffness of the abdominal aorta in women with rheumatoid arthritis. Rheumatology 44, 896-901
41. Vlachopoulos, C., Aznaouridis, K. and Stefanadis, C. (2006) Clinical appraisal of arterial stiffness: the Argonauts in front of the Golden Fleece. Heart 92, 1544-1550
42. Bruunsgaard, H. (2005) Physical activity and modulation of systemic low-level inflammation. J. Leukocyte Biol. 78, 819-835
43. Kasapis, C. and Thompson, P. D. (2005) The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J. Am. Coll. Cardiol. 45, 1563-1569
44. Hjelstuen, A., Anderssen, S. A., Holme, I., Seljeflot, I. and Klemsdal, T. O. (2006) Markers of inflammation are inversely related to physical activity and fitness in sedentary men with treated hypertension. Am. J. Hypertens. 19, 669-675
45. Murphy, M. H., Murtagh, E. M., Boreham, C. A., Hare, L. G. and Nevill, A. M. (2006) The effect of a worksite based walking programme on cardiovascular risk in previously sedentary civil servants. BMC Public Health 22, 136
46. Fulle, S., Mecocci, P., Fano, G. et al. (2000) Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. Free Radical Biol. Med. 29, 1252-1259
47. Jammes, Y., Steinberg, J. G., Mambrini, O., Bregeon, F. and Delliaux, S. (2005) Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. J. Intern. Med. 257, 299-310
48. Sinzinger, H., Lupattelli, G., Chehne, F., Oguogho, A. and Furberg, C. D. (2001) Isoprostane 8-epi-PGF2α is frequently increased in patients with muscle pain and/or CK-elevation after HMG-Co-enzyme-A-reductase inhibitor therapy. J. Clin. Pharm. Ther. 26, 303-310
49. Abramson, J. L., Hooper, W. C., Jones, D. P. et al. (2005) Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis 178, 115-121
50. Kakuta, Y., Aoshiba, K. and Nagai, A. (2006) C-Reactive protein products generated by neutrophil elastase promote neutrophil apoptosis. Arch. Med. Res. 37, 456-460
51. Zieman, S. J., Melenovsky, V. and Kass, D. A. (2005) Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler. Thromb. Vasc. Biol. 25, 932-943
52. Meeus, M., Nijs, J., McGregor, N. et al. (2005) Unraveling intracellular immune dysfunctions in chronic fatigue syndrome: interactions between protein kinase R activity, RNase L cleavage, and elastase activity and their clinical significance. Acta Clin. Belg. 60, 314
53. Yasmin, McEniery, C. M., Wallace, S. et al. (2005) Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler. Thromb. Vasc. Biol. 25, 372-378
54. Vlachopoulos, C., Aznaouridis, K., Dima, I. et al. (2007) Negative association between serum levels of matrix metalloproteinases-2 and -9 and aortic stiffness in healthy adults. Int. J. Cardiol. 122, 232-238